PT - JOURNAL ARTICLE AU - Hauspurg, Alisse AU - Bryan, Samantha AU - Jeyabalan, Arun AU - Davis, Esa M. AU - Hart, Renee AU - Shirriel, Jada AU - Muldoon, Matthew AU - Catov, Janet TI - Blood pressure trajectories through the first year postpartum following a hypertensive disorder of pregnancy AID - 10.1101/2023.10.13.23297033 DP - 2023 Jan 01 TA - medRxiv PG - 2023.10.13.23297033 4099 - http://medrxiv.org/content/early/2023/10/15/2023.10.13.23297033.short 4100 - http://medrxiv.org/content/early/2023/10/15/2023.10.13.23297033.full AB - Background Hypertensive disorders of pregnancy (HDP) are associated with future cardiovascular disease, predominantly through development of chronic hypertension, however the patterns of blood pressure recovery following a HDP are understudied. We sought to characterize the subtypes of hypertension (isolated systolic, isolated diastolic, systolic diastolic) and compare pregnancy and postpartum blood pressure trajectories among individuals with hypertensive disorders of pregnancy (HDP) who developed persistent hypertension at one year postpartum compared to individuals with normalization of blood pressure (BP).Methods We used data from a randomized controlled clinical trial of overweight and obese individuals with a physician adjudicated HDP conducted in the first year after delivery. Individuals with pre-pregnancy hypertension were excluded. Pregnancy BPs were obtained during prenatal visits, postpartum BPs were prospectively obtained through home BP monitoring, one week per month during the first year postpartum. Demographic characteristics and trajectories were compared based on whether or not individuals developed persistent hypertension (stage 1 or greater; systolic BP ≥130, diastolic BP ≥80 mmHg or use of anti-hypertensive medications) at one year. We further classified individuals with persistent hypertension as having isolated diastolic, isolated systolic and systolic diastolic hypertension. We used repeated BP measures to fit separate mixed-effects linear regression models for pregnancy and postpartum with participant identifier as random intercepts and weeks of pregnancy or months postpartum as a fixed effect expressed using restricted cubic splines. Models were compared using likelihood ratio test.Results We included 129 individuals who contributed a mean of 95.4 (95%CI 76.7-115.1) BP readings during and following pregnancy. In total, 75 individuals (58%) progressed to stage 1 or stage 2 hypertension by 1 year postpartum. At one-year postpartum, among those with persistent hypertension, 43 (69%) had isolated diastolic hypertension, 2 (3%) had isolated systolic hypertension and 17 (27%) had systolic-diastolic hypertension. Individuals with persistent hypertension were about 2 years older, delivered at earlier gestational ages and tended to have a higher BMI at one year postpartum compared to those with BP normalization. There were no differences in BP at first prenatal visit or BP trajectories during pregnancy. Individuals with persistent hypertension had a more adverse BP trajectory (p<0.01 for systolic and diastolic BP) in the first year postpartum. These differences persisted in multivariable models after adjustment for pre-pregnancy BMI and type of HDP (p<0.01 for systolic and diastolic BP).Conclusions Blood pressure trajectories in the first year postpartum, but not during pregnancy, may provide critical information for risk stratification after a HDP. In our study, a high proportion of individuals had ongoing hypertension, predominantly isolated diastolic hypertension. If confirmed in a larger cohort, this may provide insight into intervention development following a HDP.CLINICAL TRIALS REGISTRATION URL: https://clinicaltrials.gov/ct2/show/NCT03749746Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03749746Funding StatementThis work was supported by the Jewish Healthcare Foundation, Amy Roberts Health Promotion Award, by funds from Magee-Womens Research Institute's Erie initiative, The Erie Community Foundation and Hamot Health Foundation and by NIH/ORWH Building Interdisciplinary Research Careers in Women's Health (BIRCWH) NIH K12HD043441 to AH. Dr Esa Davis is a member of the US Preventive Services Task Force (USPSTF); this article does not necessarily represent the views and polices of the USPSTF.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The protocol was approved by the Institutional Review Board of the University of Pittsburgh (STUDY18080007) and all participants provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData that support the findings of this study are available from the corresponding author upon reasonable request and following IRB rules and privacy regulations.